BioSpace has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
BioSpace Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs Read More »
The initiative could tackle the first-mover disadvantage some CDMOs believe deters early customers, but leaders at companies including Novo Nordisk see hurdles to implementing the changes.
CDMOs Pin Hopes for Accelerating Uptake at New US Sites on FDA’s PreCheck Program Read More »
Henry Gosebruch, who has $3.5 billion in capital to deploy, is thinking broad as he steers the decades-old biotech out of years of turmoil.
JPM26: Galapagos’ New CEO Is Here to Finally Turn The Ship Around Read More »
In this bonus episode, BioSpace’s Vice President of Marketing Chantal Dresner and Careers Editor Angela Gabriel take a look at Q4 job market performance and what it signals for 2026.
Despite the late-stage miss, analysts maintained confidence in the Epkinly program, with Truist Securities saying the result “doesn’t waver our optimism” regarding the bispecific antibody’s ongoing frontline trial.
Two more biopharma companies—the hair-growth specialist Veradermics and cancer-focused Eikon Therapeutics—have announced their IPOs this year. Meanwhile, Aktis Oncology began trading publicly earlier this month.
2026 IPO Train Keeps Chugging as AgomAb, SpyGlass Eye Nasdaq Debut Read More »
La industria del iGaming avanza hacia modelos técnicos más flexibles y precisos. La adaptación en tiempo real ya no es una promesa lejana, sino una práctica en expansión. Los operadores buscan sistemas que respondan al comportamiento del usuario sin fricc …
Adaptación de juegos en tiempo real mediante IA en la nube como futuro del iGaming Read More »
Despite ushering in the current GLP-1 era, Novo Nordisk has fallen behind its chief rival Eli Lilly, which has exceeded the Danish pharma in terms of sales.
Novo Rises as Oral Wegovy Reaches Over 3,000 Patients in First Week of Launch Read More »
Una investigación reciente ha permitido identificar genes relacionados con la predisposición a desarrollar adenocarcinoma ductal de páncreas (el tipo más habitual de cáncer de páncreas), y también con el pronóstico de la enfermedad, una vez ha …
Hallan más genes que predisponen al cáncer de páncreas Read More »
El cólera sigue siendo un gran desafío global de salud pública, con una estimación anual de entre 1,3 y 4 millones de casos y decenas de miles de muertes reportadas en todo el mundo. Causada por la bacteria Vibrio cholerae, la enfermedad se propaga principalmente a trav&e …
Descubren cómo se activa la virulencia del cólera Read More »
